lambda phage cdna expression library (Chiron Corporation)
90
Structured Review
Chiron Corporation
lambda phage cdna expression library
Lambda Phage Cdna Expression Library, supplied by Chiron Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdna+lambda+phage+library/lambda+phage+cdna+expression+library/pmc03501656-444-17-13
Average 90 stars, based on 1 article reviews
Lambda Phage Cdna Expression Library, supplied by Chiron Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdna+lambda+phage+library/lambda+phage+cdna+expression+library/pmc03501656-444-17-13
Average 90 stars, based on 1 article reviews
lambda phage cdna expression library - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: The phantom menace Article Snippet: The culprit, Article Title: Bibliometric analysis of the top-cited gastroenterology and hepatology articles Article Snippet: 2 , Choo et al, 1989 , Isolation of a cDNA clone derived from a blood-borne non-A, Article Title: Discovery of the hepatitis C virus. Article Snippet: DOI:10.1111/j.1478-3231.2008.01925.x Abstract After nearly 6 years of intensive investigations between 1982 and 1988 in my laboratory at Chiron corporation, in which numerous molecular biological methods were used to investigate the viral aetiology of parenterally transmitted non-A, non-B viral hepatitis (NANBH), a single cDNA clone (5-1-1) was isolated that was shown to be derived from a new flavi-like virus, termed the hepatitis C virus (HCV).. After screening hundreds of millions of bacterial cDNA clones derived from different liver and plasma samples obtained from experimentally infected chimpanzees, a single HCV clone was eventually isolated using a novel, blind immunoscreening method in which antibodies derived from a clinically diagnosed NANBH patient were used to identify a cDNA clone encoding an immunodominant epitope within HCV nonstructural protein 4.. Its viral origin was demonstrated by its specific hybridization to a large single-stranded RNA molecule of 10 000 nucleotides found only in NANBH-infected samples that shared distant sequence identity with flaviviruses. Control:Article Title: Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis. Article Snippet: ABBREVIATIONS: ARC = American Red Cross; FT = first-time (donor); IR-WP = incidence rate-window period; MP = minipool; NANBH = non-A, non-B hepatitis; PTH = posttransfusion hepatitis; RPT = repeat; TA = transfusion-associated; TSS = Transfusion Safety Study; TTVI(s) = transfusion-transmitted viral infection(s); TTVS = Transfusion-Transmitted Viruses Study; WNV = West Nile virus; WP(s) = window period(s). Virus:Article Title: Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis. Article Snippet: ABBREVIATIONS: ARC = American Red Cross; FT = first-time (donor); IR-WP = incidence rate-window period; MP = minipool; NANBH = non-A, non-B hepatitis; PTH = posttransfusion hepatitis; RPT = repeat; TA = transfusion-associated; TSS = Transfusion Safety Study; TTVI(s) = transfusion-transmitted viral infection(s); TTVS = Transfusion-Transmitted Viruses Study; WNV = West Nile virus; WP(s) = window period(s). Article Title: Road to elimination of HCV: Clinical challenges in HCV management. Article Snippet: In 2020, the Nobel Prize in Medicine was award to Harvey J.. Alter, Michael Houghton and Charles M. Rice for their work on the discovery of hepatitis C virus (HCV).. The race to identify and screen the ‘nonA, nonB’ virus contaminating the blood supply was a transformative technical breakthrough that resulted in not only a safer blood supply but also in major advances in virology, immunology, diagnostic testing and liver pathology.1 At the National Institutes of Health, Harvey J. Expressing:Article Title: Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis. Article Snippet: ABBREVIATIONS: ARC = American Red Cross; FT = first-time (donor); IR-WP = incidence rate-window period; MP = minipool; NANBH = non-A, non-B hepatitis; PTH = posttransfusion hepatitis; RPT = repeat; TA = transfusion-associated; TSS = Transfusion Safety Study; TTVI(s) = transfusion-transmitted viral infection(s); TTVS = Transfusion-Transmitted Viruses Study; WNV = West Nile virus; WP(s) = window period(s). Article Title: The History of Tumor Virology Article Snippet: .. To achieve this goal, Michael Houghton and a group of scientists at the Chiron Corporation generated a Article Title: Hepatitis C: a successful story of cure Article Snippet: On September 23, the 2016 Lasker-DeBakey clinical medical research award ceremony was celebrated in New York City.. This annual prize has been awarded by the Lasker Foundation for over 71 years, and it is the most prestigious biomedical award in the United States, popularly known as ‘‘America’s Nobel Prize’’.. Indeed, 87 Lasker laureates have received the Nobel Prize, including 41 within the last 30 years (one example is the Chinese pharmaceutical chemist Youyou Tu, who won the 2011 Lasker-DeBakey award and four years later received the Nobel Prize). Article Title: The History of Tumor Virology Article Snippet: .. To achieve this goal, Michael Houghton and a group of scientists at the Chiron Corporation generated a Clinical Proteomics:Article Title: Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis. Article Snippet: ABBREVIATIONS: ARC = American Red Cross; FT = first-time (donor); IR-WP = incidence rate-window period; MP = minipool; NANBH = non-A, non-B hepatitis; PTH = posttransfusion hepatitis; RPT = repeat; TA = transfusion-associated; TSS = Transfusion Safety Study; TTVI(s) = transfusion-transmitted viral infection(s); TTVS = Transfusion-Transmitted Viruses Study; WNV = West Nile virus; WP(s) = window period(s). Article Title: The History of Tumor Virology Article Snippet: .. To achieve this goal, Michael Houghton and a group of scientists at the Chiron Corporation generated a Article Title: Road to elimination of HCV: Clinical challenges in HCV management. Article Snippet: In 2020, the Nobel Prize in Medicine was award to Harvey J.. Alter, Michael Houghton and Charles M. Rice for their work on the discovery of hepatitis C virus (HCV).. The race to identify and screen the ‘nonA, nonB’ virus contaminating the blood supply was a transformative technical breakthrough that resulted in not only a safer blood supply but also in major advances in virology, immunology, diagnostic testing and liver pathology.1 At the National Institutes of Health, Harvey J. Article Title: Hepatitis C: a successful story of cure Article Snippet: On September 23, the 2016 Lasker-DeBakey clinical medical research award ceremony was celebrated in New York City.. This annual prize has been awarded by the Lasker Foundation for over 71 years, and it is the most prestigious biomedical award in the United States, popularly known as ‘‘America’s Nobel Prize’’.. Indeed, 87 Lasker laureates have received the Nobel Prize, including 41 within the last 30 years (one example is the Chinese pharmaceutical chemist Youyou Tu, who won the 2011 Lasker-DeBakey award and four years later received the Nobel Prize). Article Title: The History of Tumor Virology Article Snippet: .. To achieve this goal, Michael Houghton and a group of scientists at the Chiron Corporation generated a Generated:Article Title: The History of Tumor Virology Article Snippet: .. To achieve this goal, Michael Houghton and a group of scientists at the Chiron Corporation generated a Article Title: Road to elimination of HCV: Clinical challenges in HCV management. Article Snippet: In 2020, the Nobel Prize in Medicine was award to Harvey J.. Alter, Michael Houghton and Charles M. Rice for their work on the discovery of hepatitis C virus (HCV).. The race to identify and screen the ‘nonA, nonB’ virus contaminating the blood supply was a transformative technical breakthrough that resulted in not only a safer blood supply but also in major advances in virology, immunology, diagnostic testing and liver pathology.1 At the National Institutes of Health, Harvey J. Article Title: Hepatitis C: a successful story of cure Article Snippet: On September 23, the 2016 Lasker-DeBakey clinical medical research award ceremony was celebrated in New York City.. This annual prize has been awarded by the Lasker Foundation for over 71 years, and it is the most prestigious biomedical award in the United States, popularly known as ‘‘America’s Nobel Prize’’.. Indeed, 87 Lasker laureates have received the Nobel Prize, including 41 within the last 30 years (one example is the Chinese pharmaceutical chemist Youyou Tu, who won the 2011 Lasker-DeBakey award and four years later received the Nobel Prize). Article Title: The History of Tumor Virology Article Snippet: .. To achieve this goal, Michael Houghton and a group of scientists at the Chiron Corporation generated a Infection:Article Title: The History of Tumor Virology Article Snippet: .. To achieve this goal, Michael Houghton and a group of scientists at the Chiron Corporation generated a Article Title: The History of Tumor Virology Article Snippet: .. To achieve this goal, Michael Houghton and a group of scientists at the Chiron Corporation generated a Cloning:Article Title: Road to elimination of HCV: Clinical challenges in HCV management. Article Snippet: In 2020, the Nobel Prize in Medicine was award to Harvey J.. Alter, Michael Houghton and Charles M. Rice for their work on the discovery of hepatitis C virus (HCV).. The race to identify and screen the ‘nonA, nonB’ virus contaminating the blood supply was a transformative technical breakthrough that resulted in not only a safer blood supply but also in major advances in virology, immunology, diagnostic testing and liver pathology.1 At the National Institutes of Health, Harvey J. Bacteria:Article Title: Road to elimination of HCV: Clinical challenges in HCV management. Article Snippet: In 2020, the Nobel Prize in Medicine was award to Harvey J.. Alter, Michael Houghton and Charles M. Rice for their work on the discovery of hepatitis C virus (HCV).. The race to identify and screen the ‘nonA, nonB’ virus contaminating the blood supply was a transformative technical breakthrough that resulted in not only a safer blood supply but also in major advances in virology, immunology, diagnostic testing and liver pathology.1 At the National Institutes of Health, Harvey J. Derivative Assay:Article Title: Road to elimination of HCV: Clinical challenges in HCV management. Article Snippet: In 2020, the Nobel Prize in Medicine was award to Harvey J.. Alter, Michael Houghton and Charles M. Rice for their work on the discovery of hepatitis C virus (HCV).. The race to identify and screen the ‘nonA, nonB’ virus contaminating the blood supply was a transformative technical breakthrough that resulted in not only a safer blood supply but also in major advances in virology, immunology, diagnostic testing and liver pathology.1 At the National Institutes of Health, Harvey J. Binding Assay:Article Title: Road to elimination of HCV: Clinical challenges in HCV management. Article Snippet: In 2020, the Nobel Prize in Medicine was award to Harvey J.. Alter, Michael Houghton and Charles M. Rice for their work on the discovery of hepatitis C virus (HCV).. The race to identify and screen the ‘nonA, nonB’ virus contaminating the blood supply was a transformative technical breakthrough that resulted in not only a safer blood supply but also in major advances in virology, immunology, diagnostic testing and liver pathology.1 At the National Institutes of Health, Harvey J. Sequencing:Article Title: Road to elimination of HCV: Clinical challenges in HCV management. Article Snippet: In 2020, the Nobel Prize in Medicine was award to Harvey J.. Alter, Michael Houghton and Charles M. Rice for their work on the discovery of hepatitis C virus (HCV).. The race to identify and screen the ‘nonA, nonB’ virus contaminating the blood supply was a transformative technical breakthrough that resulted in not only a safer blood supply but also in major advances in virology, immunology, diagnostic testing and liver pathology.1 At the National Institutes of Health, Harvey J. |